Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

KRSA holding history

Korsana Biosciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRSA overviewAll 13F holders of KRSAFull Q2 2026 holdings

Shares (Q2 2026)
3,135
Value
$10.6K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of KRSA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,135$10.6K<0.1%−256−7.5%ReducedHolders
Q1 20263,391$5.26K<0.1%+3,015+801.9%AddedHolders
Q4 2025376$478<0.1%+327+667.3%AddedHolders
Q3 202549$113<0.1%−9,678−99.5%ReducedHolders
Q2 20259,727$28.3K<0.1%−3,274−25.2%ReducedHolders
Q1 202513,001$32.5K<0.1%+3,334+34.5%AddedHolders
Q4 20249,667$31.1K<0.1%+9,522+6,566.9%AddedHolders
Q3 2024145$376<0.1%−2,561−94.6%ReducedHolders
Q2 20242,706$6.22K<0.1%+182+7.2%AddedHolders
Q1 20242,524$8.08K<0.1%+296+13.3%AddedHolders
Q4 20232,228$7.46K<0.1%+1,952+707.2%AddedHolders
Q3 2023276$944<0.1%+90+48.4%AddedHolders
Q2 2023186$766<0.1%−526−73.9%ReducedConverted for a 1-for-20 splitHolders
Q1 202314,247$6.18K<0.1%−3,965−21.8%ReducedHolders
Q4 202218,212$12.0K<0.1%+18,212NewHolders
Q2 20220$00.0%−3,645−100.0%Sold outHolders
Q1 20223,645$4.00K<0.1%+3,645NewHolders
Q4 20210$00.0%−3,544−100.0%Sold outHolders
Q3 20213,544$11.0K<0.1%+3,274+1,212.6%AddedHolders
Q2 2021270$1.00K<0.1%−4,412−94.2%ReducedHolders
Q1 20214,682$13.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.